Cerebrofaciothoracic dysplasia: Four new patients with a recurrent TMCO1 pathogenic variant.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
01 2019
Historique:
received: 21 06 2018
revised: 09 10 2018
accepted: 14 10 2018
pubmed: 18 12 2018
medline: 13 2 2020
entrez: 18 12 2018
Statut: ppublish

Résumé

Biallelic loss of function variants in the TMCO1 gene have been previously demonstrated to result in cerebrofaciothoracic dysplasia (CFTD; MIM #213980). The phenotype of this condition includes severe intellectual disability, as well as distinctive craniofacial features, including brachycephaly, synophrys, arched eyebrows, "cupid's bow" upper lip, and microdontia. In addition, nonspecific skeletal anomalies are common, including bifid ribs, scoliosis, and spinal fusion. Only 19 molecularly confirmed patients have been previously described. Here, we present four patients with CFTD, including three brothers from a Pakistani background and an additional unrelated white Scottish patient. All share the characteristic craniofacial appearance, with severe intellectual disability and skeletal abnormalities. We further define the phenotype with comparison to the published literature, and present images to define the dysmorphic features in a previously unreported ethnic group. All of our patient series are homozygous for the same c.292_293del (p.Ser98*) TMCO1 pathogenic variant, which has been previously reported only in an isolated Amish population. Thus we provide evidence that CFTD may be more common than previously thought. The patients presented here further delineate the phenotypic spectrum of CFTD and provide evidence for a recurrent pathogenic variant in TMCO1.

Identifiants

pubmed: 30556256
doi: 10.1002/ajmg.a.60678
doi:

Substances chimiques

Calcium Channels 0
TMCO1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-49

Subventions

Organisme : National Institute for Health Research
Pays : International
Organisme : Wellcome Trust Sanger Institute
ID : WT098051
Pays : International
Organisme : Health Innovation Challenge Fund
ID : HICF-1009-003
Pays : International
Organisme : Department of Health [UK]
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Thabo Michael Yates (T)

Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.

Oon-Hui Ng (OH)

Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.

Amaka C Offiah (AC)

Academic Unit of Child Health, University of Sheffield, Sheffield, United Kingdom.
Radiology Department, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.

Josh Willoughby (J)

Sheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.

Jonathan N Berg (JN)

Dundee Clinical Genetics Service, Ninewells Hospital and Medical School, Dundee, United Kingdom.
DDD Study, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.

Diana S Johnson (DS)

Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH